Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histocompatibility 2, class II antigen A, alpha (H2-Aa) is a protein-coding gene in mice that encodes the alpha chain of the I-A molecule, a member of the major histocompatibility complex (MHC) class II family (UniProt P04224). It is primarily expressed on the surface of professional antigen-presenting cells, such as dendritic cells, B cells, and macrophages, where it forms a heterodimer with the H2-Ab1 beta chain (NCBI Gene 14960). The primary biological function of H2-Aa is to bind and present processed exogenous peptides to the T-cell receptors (TCR) of CD4+ T helper cells, a process fundamental to the initiation of the adaptive immune response. In disease contexts, H2-Aa is heavily involved in the pathogenesis of autoimmune disorders, where the presentation of self-peptides can trigger aberrant immune attacks (PubMed: 25607456). It also plays a critical role in the immune system's ability to recognize and respond to infectious pathogens and tumor-associated antigens. While H2-Aa itself is often a target of research-grade monoclonal antibodies like M5/114.15.2 to study immune modulation, its human orthologs (HLA-DQ) are significant targets for developing therapies for allergies and transplant rejection. Understanding the structural and functional nuances of H2-Aa is essential for the design of vaccines and immunotherapies that aim to either enhance or suppress specific immune pathways.
Presentation of exogenous peptides to CD4+ T-cell receptors to initiate adaptive immune responses.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histocompatibility 2, class II antigen A, alpha (H2-Aa) (H2-Aa).